Kuros Biosciences AG (KURN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CHF
| Market Cap | 1.06B |
| Enterprise Value | 1.04B |
| P/E Ratio | 494.84 |
| PEG Ratio | 9.69 |
| Price/Sales Ratio | 6.42 |
| Price/Book Ratio | 12.33 |
| Enterprise/Revenue | 6.33 |
| Enterprise/EBITDA | 80.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.01 |
| Operating Margin | 0.06 |
| Return On Assets | 0.02 |
| Return On Equity | 0.02 |
| Revenue | 121.3M |
| Revenue/Share | 3.31 |
| Gross Profit | 104.79M |
| EBITDA | 10.13M |
| Net Income | 2.12M |
| Diluted EPS | 0.05 |
| Total Cash | 15.66M |
| Total Cash/Share | 0.4 |
| Total Debt | 3.94M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 1.96 |
| Book Value Per Share | 1.71 |
| 52-Week Change | -26.65 |
| 52-Week High | 34.2 |
| 52-Week Low | 17.69 |
| Moving Average 50 Days | 20.01 |
| Moving Average 200 Days | 25.2 |
| Average Volume | 201,088 |
| Shares Outstanding | 39.44M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 217:200 |
| Last Split Date | October 08, 2020 |